Financial Health Assessment: U.Q.G. LIMITED

1. Financial Health Score: B+

The patient exhibits a strong constitution with a robust cash position and solid asset base, characteristic of a mature business with over 50 years of trading history. However, a recent spike in short-term liabilities and a slight contraction in overall equity prevent a top-tier rating. The business is healthy but showing symptoms of mild circulatory stress that requires monitoring.

2. Key Vital Signs

• Pulse (Cash Position): £976,189 The company has a very strong pulse. Cash at bank has nearly doubled from the previous year (£532,420), indicating excellent short-term liquidity and a healthy immune system against immediate financial shocks.
• Blood Pressure (Liquidity Ratio): 1.41 Calculated as Current Assets (£1.96M) divided by Current Liabilities (£1.39M). A ratio of 1.41 means the company can comfortably cover its short-term debts, which is healthy. However, this is a notable drop from the previous year's ratio of 1.85, indicating rising short-term pressure.
• Cholesterol (Liability-to-Asset Ratio): 43% Total liabilities (£1.39M) make up 43% of total assets (£3.2M). This is a reasonable level of financial leverage, but the sharp increase in current liabilities—from £785k to £1.39M in a single year—represents a significant buildup of "bad cholesterol" that needs to be managed.
• Weight (Net Assets): £1,665,064 The company's net worth is substantial. However, there has been a slight "weight loss" of £14,619 compared to the previous year (£1,679,683), likely indicating a trading loss or a dividend payout in the latest period.

3. Diagnosis

Overall Condition: Stable, but exhibiting signs of working capital strain.

U.Q.G. LIMITED is fundamentally a healthy patient. As a long-standing manufacturer of technical glassware, it has built up significant reserves over decades, evidenced by a strong balance sheet and over £1.6 million in shareholder funds. The recent surge in cash reserves is an excellent defensive mechanism, providing a substantial buffer against economic volatility.

However, the financial data reveals underlying symptoms of stress in the circulatory system. While current assets have grown, current liabilities have grown at a much faster rate, nearly doubling year-over-year. This has caused the net current assets (working capital) to shrink from £667k to £571k. The company is effectively carrying more short-term debt, which could be a result of delaying supplier payments to preserve cash, or taking on short-term financing to fund operations.

Additionally, debtors have swollen to £923k, meaning a significant amount of the company's blood flow is tied up in unpaid invoices rather than available cash. The slight drop in net assets and the reduction in headcount (from 20 to 19 employees) suggest the business may be contracting slightly or streamlining operations to manage costs.

4. Recommendations

1. Improve Circulation (Debtors Management): With £923k tied up in debtors, the company needs to ensure its receivables are collected promptly. Implementing stricter credit control or offering early payment discounts will help convert these outstanding amounts into cash, relieving the pressure from the inflated current liabilities.
2. Monitor "Bad Cholesterol" (Current Liabilities): Investigate the root cause of the £600k increase in short-term creditors. If this represents deferred trade payments, ensure supplier relationships are not being jeopardized. If it represents new short-term debt, evaluate whether the cost of that debt is being offset by the returns on the cash held at the bank.
3. Put Cash to Work (Investment Strategy): With nearly £1M sitting in cash, the company has an opportunity to cure its working capital squeeze. Consider using a portion of these cash reserves to pay down the most expensive or pressing short-term liabilities, thereby improving the current ratio and reducing future interest or late-payment risks.
4. Regular Health Checks: Given the shift in the balance sheet structure over the last year, management should conduct monthly cash flow forecasting to ensure that the swelling short-term obligations can be met without eroding the cash buffer.